• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MARVAO MEDICAL NEXSITE STEPPED; HEMODIALYSIS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MARVAO MEDICAL NEXSITE STEPPED; HEMODIALYSIS CATHETER Back to Search Results
Catalog Number NEXHD1553201
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problems Bacterial Infection (1735); Staphylococcus Aureus (2058)
Event Date 07/03/2015
Event Type  Death  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation; therefore an analysis of the complaint device could not be completed.A review of the manufacturing documentation confirmed that there were no deviations or non-conformances that would have contributed to the reported complaint.Taking into consideration the evaluation conducted and the details of the complaint, this investigation was assigned the most probable root cause of an anticipated procedural complication.A complaint with a most probable root cause classification of an anticipated procedural complication indicates that a device-related root cause does not apply and the complaint is due to a known effect of the procedure.
 
Event Description
Study (b)(4): this nexsite device was implanted successfully on (b)(6) 2015.The physician documented that the patient had a negative blood culture before placement.On (b)(6) 2015, the patient had blood cultures drawn for surveillance.The blood cultures were (b)(6) for (b)(6) infection and it was reported that the patient had relapsing catheter associated (b)(6) bacteremia.The patient was afebrile and asymptomatic.The patient was started on vancomycin on (b)(6) 2015 and continued until (b)(6) 2015.He had also been given daptomycin as an outpatient.The patient had negative blood cultures on (b)(6) 2015.Blood cultures drawn in dialysis on (b)(6) 2015 and again on (b)(6) 2015 were (b)(6) for (b)(6).Due to degree of anaemia, hypoalbuminemia and (b)(6) blood cultures, the patient was admitted to hospital on (b)(6) 2015 for evaluation and treatment of catheter-related bloodstream infection.The catheter was removed on (b)(6) 2015 and vancomycin was given.Infectious disease consultant wanted the catheter removed and suspected he seeded his blood from an unknown source, so this was a "bystander / collateral damage " situation.It was felt that patient had developed a bloodstream infection due to possible active infection elsewhere in body.They are looking at his bones, heart valves, old grafts for source.Cultures on (b)(6) 2015 was negative.On (b)(6) 2015, rifampin was added to antibiotic regimen.The plan on (b)(6) 2015 was for 8 weeks of antibiotics.On (b)(6) 2015, the inpatient nephrology note states that the patient "looks well" and hopeful for discharge that week.The patient had a history of (b)(6) from (b)(6) 2013.In (b)(6) 2015, the patient had a right arm avg (arteriovenous graft) removed as cultures were (b)(6) for (b)(6).Tranesophageal echocardiogram did not show any vegetations and blood cultures ultimately turned negative.Antibiotics were completed in (b)(6) 2015.Cultures in (b)(6) 2015 were all "(b)(6)".The patient had ongoing (b)(6) for 4 months despite extended courses of iv vancomycin and hd catheter exchanges.
 
Manufacturer Narrative
Taking into consideration the evaluation conducted and the details of the complaint, this investigation is assigned the most probable root cause classification of caused by other.The investigation indicates device/drug/procedure/illness/co-morbidity caused the complaint event.This patient had relapsing (b)(6).
 
Event Description
The site reported that there were no cultures that were (b)(6) prior to device placement.The only outlier is a culture on (b)(6) 2015 where set 1 of 2 was (b)(6) and set 2 of 2 (same date) has no growth.Other than that, he had a history of relapsing (b)(6).He has since passed away.
 
Event Description
Additional information received from electronic database provider indicated the date of death as (b)(6) 2015.It is noted that the patient completed the study on (b)(6) 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXSITE STEPPED
Type of Device
HEMODIALYSIS CATHETER
Manufacturer (Section D)
MARVAO MEDICAL
innovation in business centre,
gmit, dublin road,
galway,
EI 
Manufacturer Contact
fiona geraghty
innovation in business centre
gmit, dublin road,
galway, 
EI  
91759301
MDR Report Key5053044
MDR Text Key24920475
Report Number3008110587-2015-00009
Device Sequence Number1
Product Code MSD
UDI-Device Identifier05391525640044
UDI-Public(01)05391525640044(17)160101(10)39352
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133796
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Reporter Occupation Physician
Type of Report Followup,Followup
Report Date 08/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/01/2016
Device Catalogue NumberNEXHD1553201
Device Lot Number39352
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/03/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received02/18/2016
04/26/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/15/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Life Threatening; Required Intervention;
Patient Age58 YR
Patient Weight76
-
-